about
Acute exacerbation of COPDBiofilm differentiation and dispersal in mucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis.Microangiopathic haemolytic anaemia and thrombocytopenia following lung volume reduction surgery in a single lung transplant recipient on maintenance tacrolimus (FK506) therapy.A randomized controlled trial of inhaled corticosteroids (ICS) on markers of epithelial-mesenchymal transition (EMT) in large airway samples in COPD: an exploratory proof of concept studyBasement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: a cross-sectional study.Airway epithelial platelet-activating factor receptor expression is markedly upregulated in chronic obstructive pulmonary disease.Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation.Reduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis.Elevated metal concentrations in the CF airway correlate with cellular injury and disease severity.Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics.High peripheral blood th17 percent associated with poor lung function in cystic fibrosis.Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary diseaseAn international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis.Methicillin-resistant Staphylococcus aureus acquisition in healthcare workers with cystic fibrosis: a retrospective cross-sectional study.Preliminary feasibility and modelling of a liquid matrix Dictyostelium discoideum virulence assay for Pseudomonas aeruginosa.Hemolysis, elevated liver enzymes, and low platelet (HELLP) syndrome in a 26-year-old woman with cystic fibrosis: a case report.Distinctive characteristics of bronchial reticular basement membrane and vessel remodelling in chronic obstructive pulmonary disease (COPD) and in asthma: they are not the same disease.Tolerance and rebound with zafirlukast in patients with persistent asthmaPseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungsVascular remodelling in asthma.Angiogenesis: a potentially critical part of remodelling in chronic airway diseases?Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis.Developing an international Pseudomonas aeruginosa reference panel.Biosignificance of bacterial cyanogenesis in the CF lung.Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis.Inhaled antibiotics in Cystic Fibrosis (CF) and non-CF bronchiectasis.Use of inhaled corticosteroids in COPD: improving efficacy.Population-based study of cystic fibrosis disease severity and haemochromatosis gene mutations.Changes in cystic fibrosis mortality in Australia, 1979-2005.Cigarette smoke and platelet-activating factor receptor dependent adhesion of Streptococcus pneumoniae to lower airway cells.Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres.The changing prevalence of pulmonary infection in adults with cystic fibrosis: A longitudinal analysis.Prospective outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease presenting to hospital: a generalisable clinical audit.Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD.Atypical presentation of acute pancreatitis in a man with pancreatic insufficiency and cystic fibrosis: a case reportManagement dilemma; a woman with cystic fibrosis and severe lung disease presenting with colonic carcinoma: a case report.Cystic fibrosis: ironing out the problem of infection?Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease.Transforming growth factor (TGF) β1 and Smad signalling pathways: A likely key to EMT-associated COPD pathogenesis.Increased vascular permeability precedes cellular inflammation as asthma control deteriorates.
P50
Q26749302-9BF44CB2-687A-4130-92FE-AA21EB8DEDD1Q33300926-C1279777-0631-4F0E-9043-6F964328A88EQ33348060-24C5C977-114F-44E0-9373-45FAD0B81C05Q33705875-41E93495-26B1-4F18-A688-EE08F62564C4Q34053645-97568804-EE3C-4847-BFBE-272E13BAB9DCQ34065677-41281876-E2CC-48D0-85FC-D5FC7C1DA559Q34286307-EB65E03D-FCC7-469D-859A-1170CFBAEBDEQ34309058-7F551B14-D351-4D05-A234-24DF0FC252E3Q35076303-D66AC2F3-ED1B-46BF-BC2D-13B72A4BF456Q35208560-251D79E9-DA09-457A-9CFB-58304292C216Q35214390-BC3D49A5-82BD-4A3A-AC0B-320A540FE0AEQ35416133-FC586B84-1C82-4DC3-9676-2725C59BDB35Q35802333-C11E311A-DD2D-46E3-B578-47DE141E4212Q36015095-5E40E57B-F230-4B0D-BE73-3C867890D8E1Q36018232-1AE30496-C6C6-40CB-A098-14A5C5AF03D3Q36156828-CF97BF09-0D80-48BB-B8D6-CE110E67697DQ36302003-22E90856-4DFA-41DB-855F-645DC0402D4DQ36717710-44B90E4A-DE38-433C-BFAF-0A89746B0E41Q37036107-24BE44C9-244C-44CB-A541-20F99F699A97Q37054843-8140AFC1-07EC-4419-AAC0-121AB4FD6B4DQ37116048-F063C22B-1798-4B7F-A1C7-46B200F78F5FQ37364571-2C0673A9-0B7A-4B38-AB3C-E7C5663561E2Q37480979-5E84251C-EEA5-44E3-919B-F4C0C8B2B60CQ37692650-3959A485-55D6-45B1-BA5D-93E799EF2238Q38059158-2A72A970-FFF0-4510-BBC9-F72383611F4FQ38397468-3C1E02CD-4DF1-4CCC-853B-317BE78B91A8Q38726082-D395B872-4DD1-463F-B0EC-3AF8B8AFF5B3Q39109346-F60845ED-9653-4640-87EB-0C64D5E5203AQ39116224-2314979D-F002-44BB-AC55-39D7588C49A9Q39355357-9CBA49D5-CC7C-47B8-9ADB-C29C90A98631Q40164055-6BF9DF9C-9D95-40FD-BD77-B4ACF9470445Q40579146-5498DD46-A63E-4553-B94C-4782884A7891Q40902551-943BF3EA-EC2B-4D66-8C04-D55A80B97222Q41196305-FCCEC6EA-0ED7-4394-B80D-9CDE480632FCQ41884278-37E3EDBF-6D70-4DA2-B8F9-FA48AA344DF4Q41959541-BCC4809B-E3B5-46DC-B59C-D5CC0AA1EA12Q42349088-97E989CD-67AC-49C0-A597-560A5F0F5F07Q42474300-9CA4B0C3-FC94-4ACA-82EF-05CE90E86A3FQ42498785-FE363806-964C-4071-84B1-8E3FD9C08195Q43254005-96D5E277-C9EA-452C-818D-A3C7209885D3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David W. Reid
@ast
David W. Reid
@en
David W. Reid
@es
David W. Reid
@nl
David W. Reid
@sl
type
label
David W. Reid
@ast
David W. Reid
@en
David W. Reid
@es
David W. Reid
@nl
David W. Reid
@sl
prefLabel
David W. Reid
@ast
David W. Reid
@en
David W. Reid
@es
David W. Reid
@nl
David W. Reid
@sl
P108
P106
P1153
55671615700
P21
P31
P496
0000-0001-9517-8212